GlobeNewswire Inc | Mar 11, 2021 07:00AM EST

March 11, 2021

CRESSKILL, N.J., March 11, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (BrainsWay or the Company), a global leader in the advanced noninvasive treatment of brain disorders, today announced that it will report its fourth quarter and full year 2020 financial results as well as operational highlights after the close of the financial markets onWednesday, March 24, 2021. The Company will host a conference call and webcast onThursday, March 25, 2021 at 8:30 AM Eastern Timeto discuss the results and provide an update on business operations.

Conference Call Dial-In & Webcast Information:

Date: Thursday, March 25, 2021Time: 8:30 AM Eastern TimeUnited States: 877-407-3982Israel: 1 809 406 247International: 201-493-6780Conference ID: 13717245Webcast: http://public.viavid.com/index.php?id=143838

The conference call will be broadcast live and will be available for replay for 30 days on the Companys website, https://investors.brainsway.com/events-and-presentations/event-calendar. Please access the Companys website at least 10 minutes ahead of the conference call to register.

About BrainsWayBrainsWay is a commercial stage medical device company focused on the development and sale of non-invasive neurostimulation products using the Companys proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology. The Company received marketing authorization from the U.S. Food and Drug Administration (FDA) for its products for a variety of patient populations, including in 2013 for patients with major depressive disorder (MDD), in 2018 for patients with obsessive-compulsive disorder (OCD), and in 2020 for patients with smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. To learn more, please visitwww.brainsway.com

Contacts:BrainsWay:Hadar LevySVP and General ManagerHadarL@brainsway.com

Investors:Bob YedidLifeSci Advisors646-597-6989Bob@LifeSciAdvisors.com